Company: CERO
Filing Date: 2025-06-16
Form Type: 424B3
Source: 0001213900-25-054769
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-16
Form: 424B3
Chunk 3
---
 1-for-20. Effective as of 12:01 a.m. Eastern Time
on June 13, 2025, the Company filed the Charter Amendment and effected a 1-for-20 reverse stock split of its shares of Common Stock (the
“Reverse Stock Split”).

As a result
of the Reverse Stock Split, every twenty (20) shares of the Company’s Common Stock issued or outstanding were automatically reclassified
into one (1) validly issued, fully-paid and non-assessable new share of Common Stock, subject to the treatment of fractional shares as
described below, without any action on the part of the holders. Proportional adjustments were made to the number of shares of Common Stock
awarded and available for issuance under the Company’s equity incentive plans, as well as the exercise price and the number of shares
issuable upon the exercise or conversion of the Company’s outstanding stock options and other equity securities under the Company’s
equity incentive plans. Additionally, all outstanding shares of preferred stock were adjusted in accordance with their terms, which resulted,
among other changes to the preferred stock terms, in proportionate adjustments being made to the number of shares issuable upon conversion
of such preferred stock and to the conversion prices of such preferred stock. All outstanding warrants were also adjusted in accordance
with their terms, which resulted, among other changes to the warrant terms, in proportionate adjustments being made to the number of shares
issuable upon exercise of such warrants and to the exercise and redemption prices of such warrants. The shares of Common Stock outstanding
following the Reverse Stock Split remain fully paid and non-assessable. The Reverse Stock Split did not affect the number of authorized
shares of Common Stock or the par value of the Common Stock.

No fractional
shares will be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive fractional shares
as a result of the Reverse Stock Split will automatically be entitled to receive an additional fraction of a share of Common Stock to
round up to the next whole share.

Trading
of the Common Stock on The Nasdaq Capital Market commenced on a split-adjusted basis at market open on June 13, 2025, under the existing
trading symbol “CERO.” The new CUSIP number for the Company’s Common Stock following the Reverse Stock Split is 71902K402.

The foregoing
description of the Charter Amendment does not purport to be complete and is qualified in its entirety by reference to